Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $12.6000 (2.52%) ($12.3200 - $12.6100) on Mon. Aug. 28, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.07% (three month average) | RSI | 40 | Latest Price | $12.6000(2.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.2% a day on average for past five trading days. | Weekly Trend | HALO advances 0.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(54%) IWO(54%) XBI(52%) IWM(49%) ARKG(48%) | Factors Impacting HALO price | HALO will decline at least -1.035% in a week (0% probabilities). VIXM(-12%) UUP(-11%) TLT(-6%) SHY(-3%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.035% (StdDev 2.07%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
5 Day Moving Average | $12.35(2.02%) | 10 Day Moving Average | $12.13(3.87%) | 20 Day Moving Average | $12.34(2.11%) | To recent high | -15.4% | To recent low | 7.1% | Market Cap | $1.722b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |